Skip to main content
Clinical Trials/IRCT2013121215765N1
IRCT2013121215765N1CompletedPhase 2

Metformin and placebo effects on TSH and thyroid volume in patients with pre-diabetes

Isfahan Endocrine and Metabolism Research Center0 sites76 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
76

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Inclusion criteria :patients with pre-diabetes [Impaired fasting plasma glucose (100 to 125 mg/dl) or impaired glucose tolerance (IGT) (2-h PG OGTT values of 140–199 mg/dL and having 18 to 65 years old] were initially included.
  • Exclusion criteria:
  • Those patients with thyroid malignancy or any other malignancy; previous-thyroxin suppression therapy at any time; obesity due to endocrine disease; Pregnancy and lactation; renal failure or liver failure; neurological or psychological disorders (depression, epilepsy, schizophrenia); heart failure; hypothyroidism or hyperthyroidism; smoking and finally iodinated contrast material exposure in the previous 6 months ago all were excluded from the study.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Isfahan Endocrine and Metabolism Research Center

Similar Trials